Epinephrine and norepinephrine compared to treat shock after myocardial infarction | ACP Hospitalist Weekly | ACP Hospitalist
Fifty-seven patients in France were randomly assigned to receive epinephrine or norepinephrine, with a primary efficacy outcome of cardiac index evolution and a primary safety outcome of refractory cardiogenic shock.
The new definition replaces the term necrosis with the concept of myocardial injury.
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
Short-term NSAIDs may still increase myocardial infarction risk after previous heart attacks | ACP Hospitalist Weekly | ACP Hospitalist
Even short-term treatment with most nonsteroidal anti-inflammatory drugs (NSAIDs) was associated with increased risk of death and a subsequent myocardial infarction (MI) in patients with prior heart attacks, reports a national cohort population
Some examples explain the Emergency Medical Treatment and Labor Act (EMTALA).
Summaries from ACP Hospitalist Weekly.
Score predicts 90-day readmission risk after myocardial infarction | ACP Hospitalist Weekly | ACP Hospitalist
Predictive factors that could be identified before discharge included age, heart failure, heart rate, dialysis, diabetes, cerebrovascular disease, peripheral artery disease, and chronic lung disease.
New score for predicting inpatient mortality after acute myocardial infarction | ACP Hospitalist Weekly | ACP Hospitalist
Factors independently associated with inpatient mortality after acute myocardial infarction included age, heart rate, systolic blood pressure, presentation after cardiac arrest, presentation in cardiogenic shock, presentation in heart failure,
Acute chest pain, acute coronary syndrome, acute myocardial infarction and bronchospastic conditions are discussed.